Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAK gel for chemotherapy-induced peripheral neuropathy
NCT00516503Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Feb 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of baclofen, amitriptyline, ketamine transdermal patch in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Cancer and Leukemia Group B. Started Feb 2008; status: completed.
02
Drugs
baclofenamitriptylineketamine transdermal patch
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT00516503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00516503.